Muenchener Rueck

Good 2020 results in COVID times, strong January renewals

25/02/21 -"• Net profit attributable to shareholders decreased by 56% to €1.21bn for 2020 but was in line with the revised company guidance • COVID-19-related losses were €3.5bn in FY2020 • The dividend ..."

PDF page sample
Pages
56
Language
English
Published on
25/02/21
Download
You may also be interested by these reports :
20/11/25
Uniqa reported a strong set of Q3 results, with continued positive top-line development and solid profitability. Despite the share price performance ...
19/11/25
Swiss Re’s 3Q25 results were mixed. On the positive side, the Q3 net profit was higher than expected, driven by P&C reinsurance amid a favourable ...
19/11/25
We have reviewed our assumptions following the publication of Swiss Re’s 3Q results. Swiss Re’s 3Q25 performance was mixed. On the positive side, net ...
19/11/25
We have updated our model following the release of Swiss Life’s 3Q figures. As a reminder, the group does not publish a full set of results at Q1 and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO